Parham Eshtehardi MD
@cardioobdoc.bsky.social
2.4K followers 1.2K following 1.4K posts
Preventive, Imaging, CardioOB Cardiologist & Scientist • Dad • Husband of a Stroke & Cancer Survivor Hero • Emory Trained • Atlanta, GA #CardioSky #CardioObstetrics #ACCRepOB 🔗 bit.ly/MyResearchPubs
Posts Media Videos Starter Packs
Pinned
cardioobdoc.bsky.social
#Skytorial for #CardioSky #MedSky newcomers
1/2

🦋 Follow #CardioSky community by using starter packs:
Cardio Journals & Societies
go.bsky.app/FfE1QRm
CardioSky I
go.bsky.app/562nfhZ
CardioSky II
go.bsky.app/R2XckyG

🦋 Add label "Cardiology" to your profile w/labeler
bsky.app/profile/meds...
Reposted by Parham Eshtehardi MD
dgk-org.bsky.social
🌟 Fortbildungsstandort Junge Kardiologie – eine Auszeichnung für engagierte Kliniken
🏅 Gütesiegel & Sichtbarkeit auf der Young DGK-Website
🎓 Kostenfreie Teilnahme an einem ausgewählten Akademiekurs
📅 Antrag bis 30.11.
➡️ herzmedizin.de/fuer-...
#DGK #YoungDGK #CardioSky
Reposted by Parham Eshtehardi MD
cvinnovations.bsky.social
The #Coronary Interventional Octagon #webinar is this Wednesday. Topic: Drug-Coated Balloons - When and How. Finalists/cases listed at: https://cvinnovations.org/2025/09/03/coronary-intoct-dcb/ #cardiology @ManosBR #cme Complimentary registration required #CardioSky #MedSky
Reposted by Parham Eshtehardi MD
Reposted by Parham Eshtehardi MD
Reposted by Parham Eshtehardi MD
womenasone.bsky.social
In Women Who Lead, we feature Dr. Cecilia Linde, Professor of Cardiology & ESC President Elect.

She shares insights on advancing heart failure research & the importance of courage, mentorship, and support for women leaders.

Read more (4 mins): womenasone.org/lates...

#CardioSky

Women Who Lead: Dr Cecilia Linde
Reposted by Parham Eshtehardi MD
jaccjournals.bsky.social
The latest issue of #JACC features Dr. Milton Packer’s exploration of the “#adipokine hypothesis,” linking adipocyte biology to #HFpEF. Along with commentaries, it also debuts an interactive tool for exploring molecular roles in HFpEF.

Explore the issue: https://bit.ly/4obvBx0 #CardioSky #MedSky
Reposted by Parham Eshtehardi MD
hmkyale.bsky.social
And be sure to check out our Adipokine Explorer!

www.jacc.org/jacc/interac...
Reposted by Parham Eshtehardi MD
hmkyale.bsky.social
After decades of disappointment in HFpEF, a new idea is shaking things up.

Could heart failure with preserved EF actually be an adipose-driven disease?

JACC’s latest issue explores “The Adipokine Hypothesis.”
@jaccjournals.bsky.social

🔗 www.jacc.org/toc/jacc/cur...
Reposted by Parham Eshtehardi MD
crfheart.bsky.social
💥 Ready to dive into the latest cardiovascular breakthroughs? Join Dr. Josep Rodés-Cabau on Sunday, October 26, for the highly anticipated presentation of the ANDES trial.

🔎 Explore the entire lineup of cutting-edge trials and research: www.tctconference.com/late-breakin...

#CardioSky #MedSky
Reposted by Parham Eshtehardi MD
cvinnovations.bsky.social
The #Coronary Interventional Octagon #webinar is this Wednesday. Topic: Drug-Coated Balloons - When and How. Finalists/cases listed at: https://cvinnovations.org/2025/09/03/coronary-intoct-dcb/ #cardiology @ManosBR #cme Complimentary registration required #CardioSky #MedSky
Reposted by Parham Eshtehardi MD
accintouch.bsky.social
👀Keep your eyes on prevention.

#NCDAcademy’s new course connects the dots between #NCDs and eye health, covering cataract, glaucoma, macular degeneration, and more. 👁️

📘 Start learning: https://bit.ly/3INnSXb

@worldheart.org #cvPrev
Reposted by Parham Eshtehardi MD
yaelmaxwell.bsky.social
"Given the known bleeding risk with oral anticoagulants, the very low AF burden questions current ESC guidelines recommending long-term oral anticoagulation," said Florian Herrmann. #EACTS2025 #CardioSky

www.tctmd.com/news/nearly-...
Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last
Data from implantable monitors show a low AF burden with time, leading some to question the need for oral anticoagulation.
www.tctmd.com
Reposted by Parham Eshtehardi MD
crfheart.bsky.social
Equip yourself to navigate the challenges of mitral regurgitation and deliver enhanced patient care at #TCT2025!

Join us for this special CME session sponsored by CRF and supported through an unrestricted educational grant by Edwards Lifesciences. 🌐https://ow.ly/vwN450XaEgO

#CardioSky
Reposted by Parham Eshtehardi MD
yaelmaxwell.bsky.social
My first story from #EACTS2025 dives into a unique analysis comparing 5-year TAVI vs SAVR mortality that provoked some strong feelings about what type of research should inform guidelines. #CardioSky
www.tctmd.com/news/savr-be...
SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data
The findings sparked a debate about the merits of RCTs vs other study designs—one surgeon urged others to “read a textbook.”
www.tctmd.com
Reposted by Parham Eshtehardi MD
ajpcardio.bsky.social
🍽️ New paper: Beyond “low salt, low fat” — time to reimagine nutrition guidance in cardiac discharge summaries to better support recovery and long-term heart health.

📖 https://www.sciencedirect.com/science/article/pii/S2666667725003964

#CardioNutrition #HeartHealth #CardioSky #MedSky
Reposted by Parham Eshtehardi MD
scainews.bsky.social
🔬 New evidence suggests #DAPT after valve-in-valve #TAVR may reduce stroke risk compared to single therapy. However, the authors caution that more data is needed to make a decisive conclusion.

Learn more about the study ➡️ https://ow.ly/ySpY50X9gE6

#CardioSky
DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required
New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.
ow.ly
Reposted by Parham Eshtehardi MD
cvinnovations.bsky.social
Deadline tomorrow! The #Peripheral Interventional Octagon "Extreme CLE and No-Option Patients" is coming up 10/23 @ 9 pm ET. Details at: https://cvinnovations.org/2025/09/08/intoct-extreme-cli/ #cardiology #CardioSky #MedSky
Reposted by Parham Eshtehardi MD
crfheart.bsky.social
Frontline professionals, it’s your time to lead.💥

The #TCT2025 Nurse and Technologist Symposium is where the future of cardiovascular care begins. Bold ideas. Real impact. Team-based innovation.

Register today! https://ow.ly/TEtU50X6FAZ

#CardioSky #MedSky
Reposted by Parham Eshtehardi MD
haoyin.bsky.social
A workflow to optimize siRNA targeting SMILR #LncRNA & #SmoothMuscleCell proliferation/migration ex vivo

30 min siRNA exposure is sufficient to penetrate ~10 lamellar layers of explanted saphenous vein media

Polyethylenimine as siRNA delivery agent

#JACCBTS 2025
www.jacc.org/doi/10.1016/...
Reposted by Parham Eshtehardi MD
scainews.bsky.social
⌛Deadline Approaching!⌛
Monday, Oct 13, is the last day to submit your #research to be featured in the upcoming #JSCAI special issue on health equity in #InterventionalCardiology.

Interested authors should contact [email protected]
Learn more about the issue➡️ https://ow.ly/amLq50X8HNT